Findings

What do systematic reviews say?

2 questions · 4 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 4 · 100%High 0 · 0%

Recurrence · adults with basal cell carcinoma of the skin

Imiquimod probably leads to higher recurrence at 3 years compared with surgical excision (moderate certainty).

2 findings from 1 review

Interventions for basal cell carcinoma of the skin 2020 · Cochrane Headline outcomes only
RR 10.3 [3.22, 32.94]
1 study · 401 participants
Moderate
Interventions for basal cell carcinoma of the skin 2020 · Cochrane Headline outcomes only
RR 7.73 [2.81, 21.3]
1 study · 383 participants
Moderate

Recurrence · adults with basal cell carcinoma of the skin

Imiquimod cream probably leads to lower recurrence at 3 years compared with MAL‐PDT (moderate certainty).

2 findings from 1 review

Interventions for basal cell carcinoma of the skin 2020 · Cochrane Headline outcomes only
RR 0.44 [0.32, 0.62]
1 study · 277 participants
Moderate
Interventions for basal cell carcinoma of the skin 2020 · Cochrane Headline outcomes only
RR 0.42 [0.31, 0.57]
1 study · 228 participants
Moderate